Iqra Ali

7PUBLICATIONS
10CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 12, 2024
In-silico identification and exploration of small molecule coumarin-1,2,3-triazole hybrids as potential EGFR inhibitors for targeting lung cancer.

Sunil Kumar, Iqra Ali, Faheem Abbas

|Nov 16, 2023
Computational exploration of novel ROCK2 inhibitors for cardiovascular disease management; insights from high-throughput virtual screening, molecular docking, DFT and MD simulation.

Iqra Ali, Muhammad Nasir Iqbal, Muhammad Ibrahim

|Aug 30, 2023
In-silico design, pharmacophore-based screening, and molecular docking studies reveal that benzimidazole-1,2,3-triazole hybrids as novel EGFR inhibitors targeting lung cancer.

Sunil Kumar, Iqra Ali, Faheem Abbas

|Aug 14, 2023
In-silico identification of small molecule benzofuran-1,2,3-triazole hybrids as potential inhibitors targeting EGFR in lung cancer via ligand-based pharmacophore modeling and molecular docking studies.

Sunil Kumar, Iqra Ali, Faheem Abbas

|May 18, 2023
Comprehensive in silico analyses of flavonoids elucidating the drug properties against kidney disease by targeting AIM2.

Mahmoud Kandeel, Muhammad Nasir Iqbal, Iqra Ali

|Apr 28, 2023
Identification and exploration of quinazoline-1,2,3-triazole inhibitors targeting EGFR in lung cancer.

Sunil Kumar, Sounok Sengupta, Iqra Ali

Pageof 2

Frequent Collaborators

4 joint publications

Sunil Kumar

4 joint publications

Deepak Kumar

3 joint publications

Faheem Abbas

1 joint publications

Simona Cavalu